Abstract
Anti- Saccharomyces cerevisiae antibodies (ASCAs) are considered 95% specific for Crohn disease (CD), but only about 60% of CD patients have the antibodies. ASCA titers have been associated with early age of onset, fibrostenosis, internal fistulas, ileal involvement, and an increased risk for small …
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have